None
Conditions
Interventions
Experimental group A:Experience with AR glasses for 10 minutes.
Experimental group B:Experience with AR glasses for 20 minutes.
Experimental group C:Experience with AR glasses for 30 minutes.
Experimental group D:Experience with AR glasses for 40 minutes.
Sponsors
Eye Hospital, Wenzhou Medical University
Eligibility
Sex/Gender
All
Age
8 Years to 12 Years
Inclusion criteria
Inclusion criteria: 1. Study participants aged between 8 and 12 years, regardless of gender; 2. Subjective refraction in both eyes of study participants 1.00D=5.0 in the study participants; 6. Study participants must not have organic lesions that affect vision, such as corneal lesions, lens problems, etc.; 7. Study participants must not have eye diseases such as coslamine allergy, superficial anterior chamber, glaucoma, or family history of glaucoma; 8. Study participants and their guardians must fully understand the purpose and risks of this trial and sign the informed consent form; 9. Study participant is able to cooperate with the trial procedures and related eye examinations.
Exclusion criteria
Exclusion criteria: If any of the following conditions are present, the individual cannot be selected: 1. Presence of strabismus and/or amblyopia. 2. Deviation of heterophoria exceeding ±5 degrees (1 degree = 1.75 prism diopters). 3. History of any ocular surgery, including strabismus surgery. 4. Congenital color vision deficiency (color blindness). 5. Any ocular, systemic, or other diseases potentially associated with myopia or influencing refractive development, such as Marfan syndrome, retinopathy of prematurity, diabetes, etc. 6. Presence of any eye injuries or diseases related to the cornea, conjunctiva, or orbit, including keratoconus and herpetic keratitis, as well as retinal pathologies. 7. Photophobia or inability to keep eyes open normally. 8. Any physiological, dermatological, or other conditions that may affect wearing glasses. 9. Participation in other clinical trials within the preceding 4 weeks before enrollment. 10. Acute or chronic diseases (including other existing acute or chronic pain) or mental health disorders that might increase risks associated with participating in the study or using experimental products, or may impact the interpretation of study outcomes. Based on the judgment of the researcher or designated medical personnel, these conditions render the subject unsuitable for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Choroidal thickness; | — |
Secondary
| Measure | Time frame |
|---|---|
| Subjective Sensation Survey Questionnaire; | — |
Countries
China
Contacts
Public ContactZhiyue Dai
Eye Hospital Affiliated to Wenzhou Medical University
Outcome results
None listed